Proinflammatory High-Density Lipoprotein Results from Oxidized Lipid Mediators in the Pathogenesis of Both Idiopathic and Associated Types of Pulmonary Arterial Hypertension

Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p

(2014) Salil Sharma et al.   CIRCULATION

High-Density Lipoprotein

(2014) Thomas F. Lüscher et al.   CIRCULATION RESEARCH

Apolipoprotein A-I mimetics

(2014) Srinivasa T. Reddy et al.   CURRENT OPINION IN LIPIDOLOGY

Trying to harness the potential of HDL: wishful thinking or sound strategy?

(2014) A. M. Fogelman   EUROPEAN HEART JOURNAL

Searching for a successful HDL-based treatment strategy

(2013) Srinivasa T. Reddy et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword

(2013) Hamid Moradi et al.   JOURNAL OF RENAL NUTRITION

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-Density Lipoprotein and 4F Peptide Reduce Systemic Inflammation by Modulating Intestinal Oxidized Lipid Metabolism

(2012) Mohamad Navab et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Atorvastatin in Pulmonary Arterial Hypertension (APATH) study

(2012) Wei-Jie Zeng et al.   EUROPEAN RESPIRATORY JOURNAL

Type I immune response cytokine–chemokine cascade is associated with pulmonary arterial hypertension

(2012) David J. Ross et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

(2011) Satoshi Imaizumi et al.   CIRCULATION JOURNAL

Key Role of 15-Lipoxygenase/15-Hydroxyeicosatetraenoic Acid in Pulmonary Vascular Remodeling and Vascular Angiogenesis Associated With Hypoxic Pulmonary Hypertension

(2011) Cui Ma et al.   HYPERTENSION

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

(2011) Mohamad Navab et al.   Nature Reviews Cardiology

Simvastatin as a Treatment for Pulmonary Hypertension Trial

(2010) M. R. Wilkins et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Basic Science of Pulmonary Arterial Hypertension for Clinicians

(2010) Stephen L. Archer et al.   CIRCULATION

8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway

(2010) Jun Ma et al.   EXPERIMENTAL CELL RESEARCH

Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation

(2009) Stefan Barlage et al.   INTENSIVE CARE MEDICINE

Hemoglobin and Its Scavenger Protein Haptoglobin Associate with ApoA-1-containing Particles and Influence the Inflammatory Properties and Function of High Density Lipoprotein

(2009) Junji Watanabe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

(2009) Nosratola D. Vaziri et al.   KIDNEY INTERNATIONAL

Oxidized phospholipids: emerging lipid mediators in pathophysiology

(2008) Hans-Peter Deigner et al.   CURRENT OPINION IN LIPIDOLOGY

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

(2008) Brian J. Van Lenten et al.   JOURNAL OF LIPID RESEARCH

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH